Recruiting studies: Malignant Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961 Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Pa
Phase 3 · 60 location(s) · ECOG-ACRIN Cancer Research Group · NCT05863195 Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoi
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT03422302 Radiology Registry on Pancreatic Malignancies
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT05714111 The IMmunotherapy Pleural 5-ALA PDT
Phase 2 · 1 location(s) · University Hospital, Lille · NCT04400539 Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Phase 1 · 40 location(s) · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · NCT06625775 Establishment and Validation of a Clinical Predictive Model for Gastrointestinal Cancer Screening Based on Patient-relat
Phase N/A · 1 location(s) · Air Force Military Medical University, China · NCT06118437 Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hemato
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07235501 GD2/CD56 Bi-specific CAR-T Cell Therapy
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT05437328 Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
NA · 1 location(s) · Dena h. Al-Tameemi · NCT07273812 Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors
Phase 1 · 1 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07482592 Precision Lung Cancer Survivorship Care Intervention
NA · 1 location(s) · Jerod L Stapleton, PhD · NCT05857995 Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Phase 1 · 1 location(s) · David Bartlett, MD · NCT07192900 Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06413992 Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patient
NA · 1 location(s) · Hospital St. Joseph, Marseille, France · NCT05027321 Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Phase N/A · 1 location(s) · University of Missouri-Columbia · NCT02838836 Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
Phase 1 · 2 location(s) · University of Chicago · NCT04295863 Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT06305299 HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours
Phase 1/Phase 2 · 1 location(s) · Hangzhou Hanx Biopharmaceuticals, Ltd. · NCT06708663 The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
Phase 2 · 1 location(s) · Aalborg University Hospital · NCT06790082 Toripalimab With Chemotherapy for Sinus Cancer
Phase 2 · 2 location(s) · Glenn J. Hanna · NCT06940180 Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression
Phase N/A · 2 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06574373 A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Phase 1 · 19 location(s) · Merck Sharp & Dohme LLC · NCT07247110 Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Phase 1 · 1 location(s) · Beijing Biotech · NCT07480941 Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924 STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer
Phase 1/Phase 2 · 1 location(s) · Angela Y. Jia, MD PhD · NCT06574880 Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
EARLY_Phase 1 · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT06828588 Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
NA · 2 location(s) · Emory University · NCT07213154 A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors
Phase 1/Phase 2 · 1 location(s) · SUNHO（China）BioPharmaceutical CO., Ltd. · NCT05991583 MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
NA · 1 location(s) · Medical College of Wisconsin · NCT05794880

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.